A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated
Clinical trial NCT04540874 · TERMINATED
Trial details
- NCT number
- NCT04540874
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2020-11-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.